Does Your Condition Qualify?
New Jersey's medical cannabis program covers 18 qualifying conditions. If you have a diagnosis on this list, you may be eligible for medical cannabis certification — covered by your insurance.
All qualifying conditions
Chronic Pain
Persistent pain lasting three months or more that has not responded adequately to conventional treatment. The most common reason NJ patients seek medical cannabis certification.
Learn more →Anxiety
Generalized anxiety, panic disorder, social anxiety, and related conditions that significantly impact quality of life and have not been adequately controlled with standard treatments.
Learn more →PTSD
Post-traumatic stress disorder affecting veterans, first responders, survivors of trauma, and others. Cannabis therapy has shown significant promise for PTSD symptom management.
Learn more →Cancer
For patients managing cancer symptoms and treatment side effects including nausea, pain, loss of appetite, and sleep disruption. Fast-tracked certification available for terminal diagnoses.
Learn more →Migraine
Chronic or episodic migraines, particularly those refractory to standard preventive and abortive treatments. Cannabis has demonstrated effectiveness as both a preventive and acute therapy.
Learn more →Epilepsy / Seizure Disorder
Epilepsy and other seizure disorders, particularly treatment-resistant forms. CBD-dominant cannabis preparations have FDA approval (Epidiolex) for specific seizure types.
Learn more →Multiple Sclerosis
MS-related spasticity, pain, sleep disturbance, and fatigue. Cannabis is one of the most studied and supported therapeutic options for MS symptom management.
Learn more →ALS
Amyotrophic lateral sclerosis (Lou Gehrig's disease). Cannabis therapy can help manage ALS symptoms including muscle cramping, spasticity, pain, and appetite loss. Expedited certification available.
Learn more →IBD / Crohn's Disease
Inflammatory bowel disease including Crohn's disease and ulcerative colitis. Cannabis has shown benefit for reducing inflammation, pain, and frequency of disease flares.
Learn more →Glaucoma
Glaucoma with elevated intraocular pressure. Cannabis has been shown to lower IOP and may help slow disease progression in patients who have not achieved adequate control with standard treatments.
Learn more →HIV / AIDS
For patients managing HIV/AIDS-related wasting syndrome, neuropathic pain, nausea from antiretroviral therapy, and fatigue. A well-established indication with strong clinical evidence.
Learn more →Muscular Dystrophy
Muscular dystrophy and related neuromuscular diseases. Cannabis may help manage spasticity, pain, sleep disruption, and the psychological burden of progressive muscle disease.
Learn more →Tourette Syndrome
Tourette syndrome with tics that have not responded adequately to conventional pharmacological treatment. Small studies suggest cannabis may reduce tic frequency and severity.
Learn more →Opioid Use Disorder
Cannabis as part of a harm-reduction strategy for opioid use disorder and opioid tapering. NJ is one of few states to recognize this as a qualifying condition, offering a meaningful exit ramp from opioids.
Learn more →Terminal Illness
Patients with terminal illness and a life expectancy of one year or less. We prioritize these patients for expedited evaluation and work with palliative care teams to ensure seamless coordination.
Learn more →Dysmenorrhea
Severe menstrual pain and cramping (dysmenorrhea) that interferes with daily functioning and has not responded to standard pain management. Newly recognized as a qualifying condition in NJ.
Learn more →Sickle Cell Anemia New 2026
Added to the NJ NJMMP in January 2026. Cannabis therapy may help manage the severe pain crises, chronic pain, and inflammation associated with sickle cell disease.
Learn more →Intractable Skeletal Muscular Spasticity
Severe spasticity of skeletal muscles that has not responded to standard antispasticity therapies, often associated with spinal cord injury, TBI, stroke, or cerebral palsy.
Learn more →Don't see your condition?
The 18 conditions above are the current qualifying conditions under the NJ Medicinal Cannabis Program. If you have a condition not on this list, you may still be a candidate for other treatments at PremierMD.
Patients with depression, other mood disorders, or treatment-resistant conditions may benefit from our sister practices: QuietMind Health (psychiatric medication management) or Spravato NJ (esketamine treatment for treatment-resistant depression).
See our FAQ